ResearchMoz

Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implants, Cardiovascular Implants, Dental Implants, Intraocular Lens And Breast Implants) - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-01-23
No. Of Pages » 98
 
 
   
 This report covers major aspects of the U.S.  implantable  medical devices market. It covers the performance of the major types of implantable devices in terms of their revenue, and the market is classified according to the number of procedures performed. The overall implantable medical devices market is classified as orthopedic implants, cardiovascular implants and other (dental,  intraocular  lens and breast) implants market. The report also provides extensive analysis of the sub-segments of the market considering 2011 as the base year for market size calculations and forecast from 2012 to 2018. 
   
 The orthopedic  implants  market is classified on the basis of types of orthopedic implants and orthopedic implantation procedures. The analysis covers the estimated...
Table of Content:

Chapter1Preface
1.1ResearchScopeAndDescription
1.2Research Methodology

Chapter2ExecutiveSummary

Chapter3U.S.ImplantableMedicalDevicesMarketAnalysis
3.1Introduction
3.1.1MarketEnvironment
3.1.2PolicyIssues
3.1.3U.S.KeyIndicatorsForImplantableMedicalDevices
3.2MarketDrivers
3.2.1 HighIncidenceOfChronicDegenerativeDiseases
3.2.2IncreaseInAgingPopulation
3.2.3RiseInPurchasingParityAndIncreaseInHealthcareExpenditure
3.3MarketRestraints
3.3.1HighPriceOfImplantableDevices
3.4MarketOpportunities
3.4.1TechnicalInnovation
3.5Porter’sFiveForcesAnalysis
3.5.1BargainingPowerOfBuyers
3.5.2BargainingPowerOfSuppliers
3.5.3ThreatOfSubstitutes
3.5.4ThreatOfNewEntrants
3.5.5CompetitiveRivalry
3.6MarketAttractivenessAnalysis
3.6.1U.S.ImplantableMedicalDevicesMarket,MarketAttractivenessAnalysis,2011

Chapter4U.S.ImplantableMedicalDevicesMarket,ProductSegmentation
4.1Overview
4.1.1CurrentScenario
4.1.1.1U.S.ImplantableMedicalDevicesMarket–TrendsandForecast,2010-2018(USDMillion)
4.1.2U.S.OrthopedicImplantsMarket
4.1.2.1Currentscenario
4.1.2.2ReconstructiveJointReplacements
4.1.2.2.1U.S.ReconstructiveJointReplacementMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.3SpinalImplants
4.1.2.3.1U.S.SpinalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.4Orthobiologics
4.1.2.5Traumafixationimplants
4.1.2.6OtherImplants
4.1.3CardiovascularImplants
4.1.3.1U.S.CardiovascularImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.3.2PacingDevices
4.1.3.3StructuralCardiacDevices
4.1.3.4CardiacStents
4.1.4DentalImplants
4.1.4.1U.S.DentalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.5IntraocularLens(Iols)
4.1.5.1U.S.IntraocularLensMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.6BreastImplants
4.1.6.1U.S.BreastImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.7OtherImplants
4.1.7.1U.S.OtherImplantableMedicalDevicesMarket,TrendsandForecast,2010–2018(USDMillion)

Chapter5U.S.ImplantableMedicalDevicesMarket,ByProcedures
5.1Overview
5.2U.S.OrthopedicImplantProcedures–TrendsAndForecast,2010–2018
5.2.1U.S.OrthopedicImplantProceduresMarket,2010–2018
5.2.2KneeReplacements
5.2.3SpinalFusionAndFixation
5.2.3.1U.S.SpinalFusionandFixationProceduresMarket,TrendandForecast,2010-2018
5.2.4FractureRepairProcedures
5.3U.S.CardiovascularImplantProcedures–TrendsAndForecast,2010–2018
5.3.1U.S.CardiovascularImplantProceduresMarket,2010–2018
5.3.2StentingProcedures
5.3.2.1U.S.StentingProceduresMarket,TrendandForecast,2010–2018
5.3.3DefibrillatorImplantation
5.3.3.1U.S.DefibrillatorImplantationProceduresMarket,TrendAndForecast,2010–2018
5.4U.S.OtherImplantProcedures–TrendsAndForecast,2010–2018
5.4.1IntraocularLensImplantProcedures
5.4.2BreastAugmentation
5.4.2.1U.S.BreastAugmentationProceduresMarket,TrendandForecast,2010–2018

Chapter6CompetitiveLandscapeAndRecommendations
6.1MarketShareAnalysisOfKeyPlayers,2011
6.1MarketStrategyForSuccess
6.2BarriersToBeConsidered

Chapter7CompanyProfiles
7.1AbbottLaboratories
7.1.1CompanyOverview
7.1.2FinancialOverview
7.1.3SwotAnalysis
7.1.4ProductPortfolio
7.1.1StrategicDevelopments
7.1.1.1BusinessDiversification
7.1.1.2R&DInitiatives
7.1.1.3InvestingInEmergingMarkets
7.1.2RecentDevelopments
7.2AlconLaboratories
7.2.1CompanyOverview
7.2.2FinancialOverview
7.2.3SwotAnalysis
7.2.4ProductPortfolio
7.2.5RecentDevelopments
7.3BiometIncorporated
7.3.1CompanyOverview
7.3.2FinancialOverview
7.3.3SwotAnalysis
7.3.4StrategicDevelopments
7.3.4.1Mergers,AcquisitionsAndTakeovers
7.3.5RecentDevelopments
7.4BauschAndLombIncorporated
7.4.1CompanyOverview
7.4.2SwotAnalysis
7.4.3StrategicDevelopments
7.4.3.1Mergers,AcquisitionsAndTakeovers
7.4.3.2NewProductLaunches
7.4.4RecentDevelopments
7.5BostonScientificCorporation
7.5.1CompanyOverview
7.5.2FinancialOverview
7.5.3SwotAnalysis
7.5.4StrategicDevelopments
7.5.4.1Mergers,AcquisitionsAndTakeovers
7.5.4.2NewProductApprovals
7.5.5RecentDevelopments
7.6JohnsonAndJohnson
7.6.1CompanyOverview
7.6.2FinancialOverview
7.6.3SwotAnalysis
7.6.4StrategicDevelopments
7.6.4.1Mergers,AcquisitionsAndTakeovers
7.6.4.2NewProductApprovalsAndLaunch
7.6.5RecentDevelopments
7.7MedtronicIncorporated
7.7.1CompanyOverview
7.7.2FinancialOverview
7.7.3SwotAnalysis
7.7.4ProductPortfolio
7.7.5StrategicDevelopments
7.7.6RecentDevelopments
7.8St.JudeMedicalIncorporated
7.8.1CompanyOverview
7.8.2FinancialOverview
7.8.3SwotAnalysis
7.8.4StrategicDevelopments
7.8.4.1SignificantR&DInvestmentsForNewProductDevelopment
7.8.4.2MergersAndAcquisitions
7.8.5RecentDevelopments
7.9SmithAndNephewPlc
7.9.1CompanyOverview
7.9.2FinancialOverview
7.9.3SwotAnalysis
7.9.4StrategicDevelopments
7.9.4.1Mergers,AcquisitionsAndTakeovers
7.9.5RecentDevelopments
7.10StrykerCorporation
7.10.1CompanyOverview
7.10.2FinancialOverview
7.10.3SwotAnalysis
7.10.4StrategicDevelopments
7.10.4.1Mergers,AcquisitionsAndTakeovers
7.10.5RecentDevelopments
7.11SynthesIncorporated
7.11.1CompanyOverview
7.11.2FinancialOverview
7.11.3SwotAnalysis
7.11.4StrategicDevelopments
7.11.5RecentDevelopments
7.12ZimmerHoldingsIncorporated
7.12.1CompanyOverview
7.12.2FinancialOverview
7.12.3SwotAnalysis
7.12.4StrategicDevelopments
7.12.5RecentDevelopments

List of Tables


Table 1 The U.S. Implantable Medical Devices Market: Snapshot

List of Figures


fig. 1 U.S. Implantable Medical Devices Market, By Types Of Implants, 2011 (Usd Million)
Fig. 2 Porter’s Five Forces Analysis For The U.S. Implantable Medical Devices Market
Fig. 3 U.S. Implantable Medical Devices Market Attractiveness Analysis, 2011
Fig. 4 U.S. Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 5 U.S. Orthopedic Implants Market, 2010 – 2018 (Usd Million)
Fig. 6 U.S. Reconstructive Joint Replacement Market, 2010 – 2018 (Usd Million)
Fig. 7 U.S. Spinal Implants Market, 2010 – 2018 (Usd Million)
Fig. 8 U.S. Cardiovascular Implants Market, 2010 – 2018 (Usd Million)
Fig. 9 U.S. Dental Implants Market, 2010 – 2018 (Usd Million)
Fig. 10 U.S. Intraocular Lens Market, 2010 – 2018 (Usd Million)
Fig. 11 U.S. Breast Implants Market, 2010 – 2018 (Usd Million)
Fig. 12 U.S. Other Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 13 U.S. OrthopedicImplants Procedures Market, 2010 – 2018 (Million)
Fig. 14 U.S. Spinal Fusion And Fixation Procedures Market, 2010 – 2018 (Million)
Fig. 15 U.S. Cardiovascular Implant Procedures Market, 2010 – 2018 (Million)
Fig. 16 U.S. Stenting Procedures Market, 2010 – 2018 (Million)
Fig. 17 U.S. Defibrillator Implantation Procedures Market, 2010 – 2018 (Million)
Fig. 18 U.S. Breast Augmentation Procedures Market, 2010 – 2018 (Million)
Fig. 19 Abbott Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 20 Alcon Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 21 Biomet Incorporated: Net Sales, 2009 – 2011 (Usd Million)
Fig. 22 Boston Scientific: Net Sales, 2009 – 2011 (Usd Million)
Fig. 23 Johnson & Johnson: Net Sales, 2009 – 2011 (Usd Million)
Fig. 24 Medtronic Inc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 25 St Jude Medical Inc.: Net Sales, 2009 – 2011 (Usd Million)
Fig. 26 Smith And Nephew Plc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 27 Stryker Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 28 Synthes Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 29 Zimmer Holdings Inc.: Net Sales, 2009 – 2011 (Usd Million)

Upcoming Reports:

Poland: market of self-loading or unloading trailers
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the self-loading or unloading trailers market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the self-loading or unloading trailers market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the...
Cholesterol Lowering Nutraceuticals Ingredient Market: Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2009 - 2018
By - Transparency Market Research
Nutraceuticals are defined as the food and dietary substances which help lower the TC (total cholesterol) levels of the body. It functions by triggering the cholesterol inhibiting hormones of the body and thereby restoring homeostasis and preventing coronary heart diseases. Nutraceuticals are currently preferred more than general cholesterol lowering medications. The cholesterol lowering nutraceuticals ingredient market bears two major segmentations, on the basis of types into: beta glucans, soluble fibers, omega 3 fatty acids, plant sterols, soy foods and others, and on the basis...
Glycated Hemoglobin Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Glycated hemoglobin (HbA1c) is a form of hemoglobin that helps to measure and identify the average plasma glucose concentration over the medium term of approximately 3 months (life-span of an average red blood cell). When hemoglobin gets exposed to plasma glucose HbA1c is formed through a non-enzymatic glycation pathway. Glycated hemoglobin build-up is observed within the red blood cell and reflects the average level of glucose to which the cell has been exposed during its life-cycle. An interesting fact observed that a person without diabetes, a typical HbA1c level reading amounts to...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Keeps High Hopes from Asia Pacific
May 27, 2015  
Ford Motor Company is continuing to make investments heavily in the mainland China, despite the company is getting signs showing a mild slowdown, which has caused the automobile manufacturer to make some small cut in the productions of vehicles. The Asia Pacific president of Ford, David Schoch, has declined to give out any details and of which all models were affected in this mentioned cuts,...
Tata Motors to Face Some Shrink in Profits Figures Due to the Declining Demand of Jaguar Land Rover in China
May 27, 2015  
The quarterly profits of Tata Motors went down, owing to the declining demand for Jaguar Land Rover vehicles in China. On Tuesday, Tata Motors informed that the net income fell around 56% to US$269 million (17.2 billion rupees) in the first quarter that ended in March, from 39.2 billion rupees that was in the previous year. The profits at the Jaguar Land Rover segments went down 33% to...
Changsha Unit of Volkswagen Group Launches Its First Product into the Market
May 27, 2015  
Just a couple of days back, the Volkswagen Group’s recent active production facility launched its very first car off the line. The Changsha plant of Volkswagen is anticipated to boost the production capacity of the German automaker in the Asia Pacific market by around 300,000 units every year. According to the Global Times on 24th of May, a brand new sedan named - Lavida arrived...
China Will Now Have its Own Forrest Gump Restaurant
May 27, 2015  
Last week, the city of Changchun in China witnessed the inauguration of the country’s very own Forrest Gump Restaurant. China is renowned across the globe as the hotbed of the most innovative and quirky restaurants and eateries, and many of them recreate the world of the various television show and film. The country already has a “Friends” themed restaurant that hails its...
Hormel Acquired the Stakes of Applegate Farms
May 27, 2015  
It was recently announced by a spokesperson from Hormel Foods that the company has paid a whopping US$775 million to take over the stakes of the renowned processed meats maker, Applegate Farms. The deal according to many will be the latest one initiated by a market leader to purchase the smaller rivals in the food industry.  When questioned about the reason behind the decision of...